DODGX
Price
$265.16
Change
-$0.90 (-0.34%)
Updated
Aug 6 closing price
Net Assets
117.42B
PGICX
Price
$18.66
Change
+$0.11 (+0.59%)
Updated
Aug 6 closing price
Net Assets
135.38M
Interact to see
Advertisement

DODGX vs PGICX

Header iconDODGX vs PGICX Comparison
Open Charts DODGX vs PGICXBanner chart's image
Dodge & Cox Stock I
Price$265.16
Change-$0.90 (-0.34%)
VolumeN/A
Net Assets117.42B
Virtus KAR Equity Income C
Price$18.66
Change+$0.11 (+0.59%)
VolumeN/A
Net Assets135.38M
DODGX vs PGICX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DODGX vs. PGICX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DODGX is a Hold and PGICX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DODGX has more cash in the bank: 117B vs. PGICX (135M). PGICX pays higher dividends than DODGX: PGICX (2.46) vs DODGX (1.39). DODGX was incepted earlier than PGICX: DODGX (61 years) vs PGICX (28 years). PGICX (2.16) is less costly to investors than DODGX (0.51). PGICX is a more actively managed with annual turnover of: 17.00 vs. DODGX (15.00). DODGX (2500) and PGICX (2500) have matching initial minimum investment requirements. PGICX annual gain was more profitable for investors over the last year : 13.83 vs. DODGX (5.02). DODGX return over 5 years is better than : 64.11 vs. PGICX (0.71).
DODGXPGICXDODGX / PGICX
Total Expense Ratio0.511.9526%
Annual Report Gross Expense Ratio0.512.1624%
Fund Existence61 years28 years-
Gain YTD3.9669.69841%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets117B135M86,667%
Annual Yield % from dividends1.392.4657%
Returns for 1 year5.0213.8336%
Returns for 3 years22.2413.95159%
Returns for 5 years64.110.718,985%
Returns for 10 years57.7823.98241%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX36.31N/A
N/A
Patient Opportunity C
MGINX10.78N/A
N/A
DWS Global Macro Inst
NSBFX64.62N/A
N/A
Nuveen Dividend Growth R6
NEQAX12.72N/A
N/A
Neuberger Berman U.S. Equity Impact A
REFGX7.97-0.01
-0.13%
Emerging Markets Equities Fund R-6